Related references
Note: Only part of the references are listed.Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
S. F. Lumley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
Koen B. Pouwels et al.
LANCET PUBLIC HEALTH (2021)
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2
Noemie Zucman et al.
CLINICAL INFECTIOUS DISEASES (2021)
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population
Nathanael Lapidus et al.
INFECTIOUS DISEASES NOW (2021)
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer et al.
ANNALS OF INTERNAL MEDICINE (2020)
Estimating the burden of SARS-CoV-2 in France
Henrik Salje et al.
SCIENCE (2020)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Silvia Stringhini et al.
LANCET (2020)
Underdetection of cases of COVID-19 in France threatens epidemic control
Giulia Pullano et al.
NATURE (2020)
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
Catherine J. Reynolds et al.
SCIENCE IMMUNOLOGY (2020)
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O'Driscoll et al.
NATURE (2020)
Reconstructing influenza incidence by deconvolution of daily mortality time series
Edward Goldstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)